Pre Exposure And Post Exposure Rabies Vaccination Solution

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. is a professional supplier of rabies vaccine solutions, focusing on biopharmaceutical research, manufacturing, and international cooperation. The Pre Exposure And Post Exposure Rabies Vaccination Solution is developed for both preventive vaccination before potential exposure and emergency prevention after rabies exposure. Based on Vero cell culture technology, the product uses inactivated rabies fixed virus (aGV strain) and follows strict pharmaceutical production procedures to provide stable vaccine quality for global healthcare applications.

Product Overview

Rabies remains one of the most serious viral infections associated with animal exposure. Effective vaccination before exposure risk and timely vaccination after exposure are important approaches for rabies prevention. AIM Honor provides a complete vaccination solution designed around different human immunization scenarios.

The Pre Exposure And Post Exposure Rabies Vaccination Solution is a freeze-dried inactivated rabies vaccine produced with Vero cell culture technology. Through virus cultivation, inactivation, purification, and lyophilization processes, the vaccine is prepared into a stable dosage form suitable for intramuscular injection.

This solution is suitable for individuals requiring preventive immunization, including people with occupational exposure risks, as well as individuals requiring vaccination after contact with suspected rabid animals. The product supports healthcare providers and distributors seeking reliable human rabies vaccine supply from a professional manufacturer.

Composition And Characteristics

The vaccine is prepared from rabies fixed virus (aGV strain) cultivated in Vero cells. After cultivation and harvesting, the virus suspension undergoes inactivation, concentration, purification, and freeze-drying processes. Human albumin, sucrose, and gelatin are added as stabilizing components during formulation.

The finished vaccine appears as a white freeze-dried cake. After adding sterile water for injection and complete reconstitution, it becomes a clear liquid suitable for administration.

Main composition information:

1. Active ingredient: Inactivated rabies fixed virus.

2. Excipients: 1% human albumin, 1% gelatin, and 5% sucrose.

3. Diluent: Sterile water for injection.

The formulation does not contain preservatives, helping maintain a controlled composition suitable for professional vaccination programs.

Technical Details

AIM Honor applies standardized pharmaceutical manufacturing procedures to ensure product consistency. The following technical parameters are based on the original product information provided by AIM Honor.

Comparison Advantage

For international buyers, understanding product differences is essential when selecting a reliable rabies vaccine supplier. AIM Honor combines Vero cell technology, controlled manufacturing processes, and professional quality management to provide a stable vaccine supply option.

Production Process

The manufacturing process of the vaccine follows strict quality management requirements. AIM Honor completes production activities in professional facilities with controlled environments to maintain product safety and consistency.

The key production procedures include:

1. Advanced purification technology: A 20m² ultrafiltration system and 600mm chromatography system are used for multi-step purification. The process helps remove foreign proteins, DNA, and other impurities while maintaining antigen quality.

2. Strict quality inspection: AIM Honor implements internal quality standards, including endotoxin control ≤10EU/dose, sterility testing, and pH value management to ensure production consistency.

3. Freeze-drying technology: A 40m² freeze-drying system is applied during preparation. The process reduces moisture content, supports antigen activity preservation, and improves product stability during storage.

Application Fields

The Pre Exposure And Post Exposure Rabies Vaccination Solution is designed to support different human rabies prevention requirements. It provides vaccination options for individuals before possible exposure and for people requiring vaccination after contact with potentially infected animals.

The product can be applied in professional healthcare settings for:

1. Occupational protection: Individuals who frequently contact animals or rabies-related materials may require preventive vaccination. These groups may include veterinarians, animal breeders, forestry workers, slaughterhouse workers, and rabies laboratory personnel.

2. Emergency exposure management: People bitten or scratched by suspected rabid animals may require timely medical evaluation and vaccination according to exposure conditions.

3. International vaccine supply programs: Pharmaceutical distributors, healthcare organizations, and medical institutions can cooperate with AIM Honor for stable vaccine procurement and professional supply support.

Vaccination Guidance

Correct vaccination procedures are essential for achieving effective immunization. Medical professionals should evaluate individual exposure conditions and follow recommended vaccination practices.

Post Exposure Schedule

After exposure to a suspected rabid animal, the wound should be cleaned immediately and professional medical advice should be obtained as soon as possible. Vaccination should be administered according to the recommended post-exposure immunization schedule.

The standard post-exposure schedule includes vaccine administration on days 0, 3, 7, 14, and 28, with five doses in total. Children follow the same general vaccination procedure according to professional medical guidance.

Pre Exposure Schedule

Individuals with a higher risk of rabies virus contact may receive preventive vaccination before exposure. The recommended pre-exposure immunization schedule consists of three doses administered on days 0, 7, and 21 or 28.

The Pre Exposure And Post Exposure Rabies Vaccination Solution provides a comprehensive approach for different prevention scenarios, helping healthcare providers manage rabies prevention requirements more efficiently.

Quality Assurance

AIM Honor focuses on pharmaceutical manufacturing quality and product reliability. The company applies professional production procedures, controlled environments, and strict testing requirements throughout the manufacturing process.

Important quality management features include:

1. Controlled production environment: Vaccine production is completed under controlled clean conditions. Key manufacturing procedures are performed according to standardized pharmaceutical requirements.

2. Purification management: Multi-step purification technology is used to improve antigen purity and support product consistency.

3. Stability control: Freeze-drying technology is applied to help maintain product quality during storage under recommended conditions.

Production Environment

The vaccine production process includes bacterial culture and passage procedures completed in a closed sterile operation system under a B+A grade clean environment.

The professional production team uses fully enclosed protective equipment and follows sterile operation standards during strain passage and cell expansion. High-precision equipment is applied to control important parameters such as temperature and pH, supporting stable cell growth and antigen quality.

Why AIM Honor

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. focuses on vaccine research, development, manufacturing, and international cooperation. Through professional production facilities and quality management systems, AIM Honor provides reliable biopharmaceutical solutions for global customers.

For buyers searching for a dependable rabies vaccine manufacturer, AIM Honor offers:

1. Professional biopharmaceutical experience: Dedicated vaccine production capability with advanced manufacturing processes.

2. Stable supply capability: Supports cooperation with international distributors and healthcare partners.

3. Technical product support: Provides professional communication regarding product information, specifications, and cooperation requirements.

FAQ

Q: What is Pre Exposure And Post Exposure Rabies Vaccination Solution?

A: Pre Exposure And Post Exposure Rabies Vaccination Solution is a human rabies prevention solution based on Vero cell culture technology. It is designed for vaccination before potential rabies exposure and vaccination after exposure to suspected rabid animals.

Q: What technology is used to produce this rabies vaccine?

A: The vaccine is produced using Vero cell culture technology. The rabies fixed virus (aGV strain) is cultivated in Vero cells and processed through inactivation, purification, and freeze-drying procedures.

Q: What are the main advantages of this vaccine?

A: The product features controlled pharmaceutical production, no preservatives, freeze-dried formulation, stable storage requirements, and professional quality management procedures. AIM Honor also provides international supply support for qualified customers.

Q: Who should receive pre-exposure rabies vaccination?

A: Pre-exposure vaccination is generally intended for people with a higher possibility of rabies virus contact, including veterinarians, animal handlers, forestry workers, slaughterhouse workers, and laboratory personnel working with rabies-related materials.

Q: How should the vaccine be stored?

A: The vaccine should be stored and transported between +2 °C and +8 °C and protected from light. Under recommended storage conditions, the validity period is 36 months.

Q: Does the product contain preservatives?

A: According to the product information provided by AIM Honor, the vaccine does not contain preservatives. The formulation contains inactivated rabies fixed virus, human albumin, gelatin, sucrose, and sterile water for injection.

Q: Can AIM Honor supply rabies vaccine products internationally?

A: AIM Honor provides professional cooperation services for global customers, including pharmaceutical distributors, healthcare organizations, and other qualified partners requiring reliable vaccine supply.

Summary

With Vero cell culture technology, standardized manufacturing procedures, and strict quality management, AIM Honor’s Pre Exposure And Post Exposure Rabies Vaccination Solution provides a reliable option for human rabies prevention. The combination of professional production capability, controlled quality processes, and international cooperation experience allows AIM Honor to support global partners seeking stable and trusted rabies vaccine solutions.